Skip to main content
Equibles

SAMSARA BIOCAPITAL, LLC

Position in AGMB — Agomab Therapeutics NV

CIK 1744967 PALO ALTO, CA
Back to AGMB Full portfolio

Position in AGMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,788,000
+$1,494,000 QoQ
Shares Held
600,000
0.0% QoQ
Ownership
1.22%
of shares outstanding
% of Portfolio
0.64%
of 13F equity value
Holder Rank
#13
of 34 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AGMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SAMSARA BIOCAPITAL, LLC holds $1,139,869,255 across 22 Biotechnology names. AGMB ranks #16 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 SRRK
Scholar Rock Holding Corp
 6,897,652 $379,370,860
2 ALMS
Alumis Inc.
 6,345,219 $178,554,462
3 MLYS
Mineralys Therapeutics, Inc.
 5,871,018 $158,400,065
4 SEPN
Septerna, Inc.
 3,149,128 $105,464,296
5 NGNE
Neurogene Inc.
 1,717,127 $54,003,644
6 KLRS
Kalaris Therapeutics, Inc.
 12,881,175 $52,426,382
7 SGP
SpyGlass Pharma, Inc.
 2,109,953 $46,967,553
8 STRO
Sutro Biopharma, Inc.
 1,062,872 $35,287,350

All Filings in AGMB

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,788,000 600,000
2026-03-31 $6,294,000 600,000